The amyloid cascade hypothesis (Hardy & Higgins, 1992; Selkoe, 1991) suggests that this increased risk is due to the supernumerary copy of the amyloid precursor protein (APP) gene that is present in Down's syndrome, which in turn is posited to increase the levels of beta‐amyloid (Aβ) present in the brain. This evidence concerns the gene APP and Down syndrome.